In this nationally representative cross-sectional study involving 4,870 patients with metabolic syndrome (MetS) from the 2007–2016 NHANES, we found a significant independent negative association between serum Klotho levels and the risk of chronic kidney disease (CKD), indicating a 35% reduction in risk. Here, KL is linked to chronic kidney disease.